16-28842995-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003321.5(TUFM):āc.1348A>Gā(p.Lys450Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000805 in 1,614,074 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_003321.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUFM | NM_003321.5 | c.1348A>G | p.Lys450Glu | missense_variant | 10/10 | ENST00000313511.8 | NP_003312.3 | |
TUFM | NM_001365360.2 | c.1264A>G | p.Lys422Glu | missense_variant | 10/10 | NP_001352289.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TUFM | ENST00000313511.8 | c.1348A>G | p.Lys450Glu | missense_variant | 10/10 | 1 | NM_003321.5 | ENSP00000322439 | P1 | |
TUFM | ENST00000569217.1 | n.657A>G | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251474Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135914
GnomAD4 exome AF: 0.0000848 AC: 124AN: 1461886Hom.: 0 Cov.: 31 AF XY: 0.0000811 AC XY: 59AN XY: 727244
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74338
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 10, 2015 | p.Lys450Glu (AAG>GAG): c.1348 A>G in exon 10 of the TUFM gene (NM_003321.4) A variant of unknown significance has been identified in the TUFM gene. The K450E missense substitution has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. Mutations in the TUFM gene are associated with the autosomal recessive disorder combined oxidative phosphorylation deficiency 4. The amino acid substitution is non-conservative in that a positively charged Lysine residue is replaced by a negatively charged Glutamic Acid residue. This change occurs at a position in the TUFM gene that is highly conserved in mammals. Multiple in-silico analysis models predict that K450E is a benign sequence change. Therefore, based on the currently available information, it is unclear whether K450E is a disease-causing mutation or a rare benign variant. The variant is found in MITONUC-MITOP panel(s). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 24, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 215314). This variant has not been reported in the literature in individuals affected with TUFM-related conditions. This variant is present in population databases (rs199674838, gnomAD 0.02%). This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 450 of the TUFM protein (p.Lys450Glu). - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 27, 2022 | The c.1348A>G (p.K450E) alteration is located in exon 10 (coding exon 10) of the TUFM gene. This alteration results from a A to G substitution at nucleotide position 1348, causing the lysine (K) at amino acid position 450 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Combined oxidative phosphorylation defect type 4 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Apr 11, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at